Bay Street News, 2024

IND clearance for GTB-3650, a 2ndgeneration nanobody TriKE®for treatment of CD33+ leukemia expected in Q2 2024 Phase 1 trial initiation […]

Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA™ […]

• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid (“NCIB”) Subsequent to […]

LOS ANGELES, May 15, 2024 (GLOBE NEWSWIRE) — NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), […]

SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) —  Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, […]

MISSISSAUGA, Ontario, May 15, 2024 (GLOBE NEWSWIRE) — Bird Construction Inc. (TSX: BDT) is pleased to announce the election of […]

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) — Element Fleet Management Corp. (TSX:EFN) (“Element” or the “Company”), the largest publicly traded, […]

CALGARY, Alberta, May 15, 2024 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX-V: QIS) (OTC Pink: QIFTF) (“Quorum”), a North […]

CALGARY, Alberta, May 15, 2024 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or […]

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased […]